Stage III NSCLC treatment options: too many choices
2024-01-01 Asmara, Od; Hardavella, G; Ramella, S; Petersen, Rh; Tietzova, I; Boerma, Ec; Tenda, Ed; Bouterfas, A; Heuvelmans, Ma; van Geffen, Wh
Novel Skin Toxicity of Epidermal Growth Factor Receptor Inhibitors: A Case of Intertrigo-Like Eruption in a Patient with Metastatic Colorectal Cancer Treated with Cetuximab
2021-01-01 Coppola, R; Santo, B; Ramella, S; Panasiti, V
Current state of interventional radiotherapy (brachytherapy) education in Italy: results of the INTERACTS survey
2019-01-01 Tagliaferri, L; Kovács, G; Aristei, C; De Sanctis, V; Barbera, F; Morganti, Ag; Casá, C; Pieters, Br; Russi, E; Livi, L; Corvó, R; Giovagnoni, A; Ricardi, U; Valentini, V; Magrini, Sm; Di Cesare, E; Pergolizzi, S; Fossa, Bj; Gardani, G; Pacelli, R; Cappabianca, S; Krengli, M; Pomerri, F; Lo Casto, A; Paiar, F; Tombolini, V; Scopinaro, F; Santoni, R; Ramella, S; Spanu, A; Pirtoli, L
Segmentectomy vs. Lobectomy in stage IA non-small cell lung cancer: A systematic review and meta-analysis of perioperative and survival outcomes
2024-01-01 Bertolaccini, L.; Tralongo, A. C.; Del Re, M.; Facchinetti, F.; Ferrara, R.; Franchina, T.; Graziano, P.; Malapelle, U.; Menis, J.; Passaro, A.; Pilotto, S.; Ramella, S.; Rossi, G.; Trisolini, R.; Cinquini, M.; Passiglia, F.; Novello, S.
Radiotherapy and Immunotherapy: The Power of the Teamwork for the Treatment of NSCLC
2022-01-01 Bassanelli, M.; Ramella, S.; Zeuli, M.; Ceribelli, A.
Sequential chemo-hypofractionated RT versus concurrent standard CRT for locally advanced NSCLC: GRADE recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
2021-01-01 Merlotti, A.; Bruni, A.; Borghetti, P.; Ramella, S.; Scotti, V.; Trovo, M.; Chiari, R.; Lohr, F.; Ricardi, U.; Bria, E.; Pappagallo, G. L.; D'Angelillo, R. M.; Arcangeli, S.
Postoperative radiotherapy (PORT) in NSCLC: The end of a love? It is never too good to trust what appears
2022-01-01 Arcangeli, S.; Ramella, S.
Open issues in the therapeutic management of unresectable stage III NSCLC in the immunotherapy era
2022-01-01 Catania, C.; Piperno, G.; Russo, A.; Greco, C.; Agustoni, F.; Scotti, V.; Proto, C.; Sangalli, C.; Patani, F.; Santacaterina, A.; Di Pietro Paolo, M.; Agresti, B.; Filippi, A. R.; Ramella, S.
Role of Postoperative Radiotherapy in the Management for Resected NSCLC – Decision Criteria in Clinical Routine Pre- and Post-LungART
2021-01-01 Suveg, K.; Le Pechoux, C.; Faivre-Finn, C.; Putora, P. M.; De Ruysscher, D.; Widder, J.; Van Houtte, P.; Troost, E. G. C.; Slotman, B. J.; Ramella, S.; Pottgen, C.; Peeters, S. T. H.; Nestle, U.; Mcdonald, F.; Dziadziuszko, R.; Belderbos, J.; Ricardi, U.; Manapov, F.; Lievens, Y.; Geets, X.; Dieckmann, K.; Guckenberger, M.; Andratschke, N.; Glatzer, M.
Treatment of oropharyngeal squamous cell carcinoma: Is swallowing quality better after TORS or RT?
2023-01-01 Campo, F.; Iocca, O.; De Virgilio, A.; Mazzola, F.; Mercante, G.; Pichi, B.; Holsinger, F. C.; Di Maio, P.; Ramella, S.; Pellini, R.
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study
2023-01-01 Nicosia, L.; Franceschini, D.; Perrone-Congedi, F.; Molinari, A.; Gerardi, M. A.; Rigo, M.; Mazzola, R.; Perna, M.; Scotti, V.; Fodor, A.; Iurato, A.; Pasqualetti, F.; Gadducci, G.; Chiesa, S.; Niespolo, R. M.; Bruni, A.; Cappelli, A.; D'Angelo, E.; Borghetti, P.; Di Marzo, A.; Ravasio, A.; De Bari, B.; Sepulcri, M.; Aiello, D.; Mortellaro, G.; Sangalli, C.; Franceschini, M.; Montesi, G.; Aquilanti, F. M.; Lunardi, G.; Valdagni, R.; Fazio, I.; Scarzello, G.; Vavassori, V.; Maranzano, E.; Maria Magrini, S.; Arcangeli, S.; Gambacorta, M. A.; Valentini, V.; Paiar, F.; Ramella, S.; Di Muzio, N. G.; Loi, M.; Jereczek-Fossa, B. A.; Casamassima, F.; Osti, M. F.; Scorsetti, M.; Alongi, F.
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium
2023-01-01 Kroeze, S. G. C.; Pavic, M.; Stellamans, K.; Lievens, Y.; Becherini, C.; Scorsetti, M.; Alongi, F.; Ricardi, U.; Jereczek-Fossa, B. A.; Westhoff, P.; But-Hadzic, J.; Widder, J.; Geets, X.; Bral, S.; Lambrecht, M.; Billiet, C.; Sirak, I.; Ramella, S.; Giovanni Battista, I.; Benavente, S.; Zapatero, A.; Romero, F.; Zilli, T.; Khanfir, K.; Hemmatazad, H.; de Bari, B.; Klass, D. N.; Adnan, S.; Peulen, H.; Salinas Ramos, J.; Strijbos, M.; Popat, S.; Ost, P.; Guckenberger, M.
The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group
2021-01-01 Franzese, C.; Marvaso, G.; Francolini, G.; Borghetti, P.; Trodella, L. E.; Sepulcri, M.; Matrone, F.; Nicosia, L.; Timon, G.; Ognibene, L.; Vinciguerra, A.; Alongi, F.; Bortolus, R.; Corti, L.; Ramella, S.; Magrini, S. M.; Livi, L.; Jereczek-Fossa, B. A.; Scorsetti, M.; Arcangeli, S.
Management of the patient with extensive stage microcytoma. The importance of collaboration between oncology and radiotherapy
2023-01-01 Minuti, G.; Stefani, A.; Trodella, L.; Cappellini, G. A.; Cecere, F.; Dionisi, F.; Di Salvatore, M.; Mariotti, S.; Mazzarella, C.; Nelli, F.; Pisegna, S.; Ricciardi, S.; Russano, M.; Ramella, S.; Bria, E.; Cappuzzo, F.
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study
2022-01-01 Nicosia, L.; Franceschini, D.; Perrone-Congedi, F.; Casamassima, F.; Gerardi, M. A.; Rigo, M.; Mazzola, R.; Perna, M.; Scotti, V.; Fodor, A.; Iurato, A.; Pasqualetti, F.; Gadducci, G.; Chiesa, S.; Niespolo, R. M.; Bruni, A.; Alicino, G.; Frassinelli, L.; Borghetti, P.; Di Marzo, A.; Ravasio, A.; De Bari, B.; Sepulcri, M.; Aiello, D.; Mortellaro, G.; Sangalli, C.; Franceschini, M.; Montesi, G.; Aquilanti, F. M.; Lunardi, G.; Valdagni, R.; Fazio, I.; Scarzello, G.; Corti, L.; Vavassori, V.; Maranzano, E.; Magrini, S. M.; Arcangeli, S.; Gambacorta, M. A.; Valentini, V.; Paiar, F.; Ramella, S.; Di Muzio, N. G.; Livi, L.; Jereczek-Fossa, B. A.; Osti, M. F.; Scorsetti, M.; Alongi, F.
Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E2-RADIatE OligoCare cohort
2024-01-01 Alongi, F.; Nicosia, L.; Ricardi, U.; Scorsetti, M.; Greto, D.; Balermpas, P.; Lievens, Y.; Braam, P.; Jereczek-Fossa, B. A.; Stellamans, K.; Ratosa, I.; Simek, I. -M.; Peulen, H.; Dirix, P.; Verbeke, L.; Ramella, S.; Hemmatazad, H.; Khanfir, K.; Geets, X.; Jeene, P.; Zilli, T.; Fournier, B.; Fortpied, C.; Boakye Oppong, F.; Ost, P.; Guckenberger, M.
Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy: Real-world data from the E2-RADIatE OligoCare cohort
2024-01-01 Bultijnck, R.; Van Hemelrijck, M.; Fonteyne, V.; Livi, L.; Jereczek-Fossa, B. A.; Hemmatazad, H.; Mayinger, M.; Peulen, H.; Verbeke, L.; Ramella, S.; Castro, P.; Tsoutsou, P.; Stellamans, K.; Shaukat, A.; Orazem, M.; Jeene, P.; Braam, P.; Verkooijen, H.; Simek, I. -M.; Alongi, F.; Clementel, E.; Fortpied, C.; Machingura, A.; Boakye Oppong, F.; Guckenberger, M.; Ost, P.
Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study
2024-01-01 Christ, S. M.; Alongi, F.; Ricardi, U.; Scorsetti, M.; Livi, L.; Balermpas, P.; Lievens, Y.; Braam, P.; Jereczek-Fossa, B. A.; Stellamans, K.; Ratosa, I.; Widder, J.; Peulen, H.; Dirix, P.; Bral, S.; Ramella, S.; Hemmatazad, H.; Khanfir, K.; Geets, X.; Jeene, P.; Zilli, T.; Fournier, B.; Ivaldi, G. B.; Clementel, E.; Fortpied, C.; Oppong, F. B.; Ost, P.; Guckenberger, M.
Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis
2021-01-01 Passiglia, F.; Cinquini, M.; Bertolaccini, L.; Del Re, M.; Facchinetti, F.; Ferrara, R.; Franchina, T.; Larici, A. R.; Malapelle, U.; Menis, J.; Passaro, A.; Pilotto, S.; Ramella, S.; Rossi, G.; Trisolini, R.; Novello, S.
Stage I Stereotactic Body Radiation Therapy Outcome's Prediction Models: Perfection Is the Enemy of Utility
2023-01-01 Ramella, S.; Soda, P.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Stage III NSCLC treatment options: too many choices | 1-gen-2024 | Asmara, Od; Hardavella, G; Ramella, S; Petersen, Rh; Tietzova, I; Boerma, Ec; Tenda, Ed; Bouterfas, A; Heuvelmans, Ma; van Geffen, Wh | |
| Novel Skin Toxicity of Epidermal Growth Factor Receptor Inhibitors: A Case of Intertrigo-Like Eruption in a Patient with Metastatic Colorectal Cancer Treated with Cetuximab | 1-gen-2021 | Coppola, R; Santo, B; Ramella, S; Panasiti, V | |
| Current state of interventional radiotherapy (brachytherapy) education in Italy: results of the INTERACTS survey | 1-gen-2019 | Tagliaferri, L; Kovács, G; Aristei, C; De Sanctis, V; Barbera, F; Morganti, Ag; Casá, C; Pieters, Br; Russi, E; Livi, L; Corvó, R; Giovagnoni, A; Ricardi, U; Valentini, V; Magrini, Sm; Di Cesare, E; Pergolizzi, S; Fossa, Bj; Gardani, G; Pacelli, R; Cappabianca, S; Krengli, M; Pomerri, F; Lo Casto, A; Paiar, F; Tombolini, V; Scopinaro, F; Santoni, R; Ramella, S; Spanu, A; Pirtoli, L | |
| Segmentectomy vs. Lobectomy in stage IA non-small cell lung cancer: A systematic review and meta-analysis of perioperative and survival outcomes | 1-gen-2024 | Bertolaccini, L.; Tralongo, A. C.; Del Re, M.; Facchinetti, F.; Ferrara, R.; Franchina, T.; Graziano, P.; Malapelle, U.; Menis, J.; Passaro, A.; Pilotto, S.; Ramella, S.; Rossi, G.; Trisolini, R.; Cinquini, M.; Passiglia, F.; Novello, S. | |
| Radiotherapy and Immunotherapy: The Power of the Teamwork for the Treatment of NSCLC | 1-gen-2022 | Bassanelli, M.; Ramella, S.; Zeuli, M.; Ceribelli, A. | |
| Sequential chemo-hypofractionated RT versus concurrent standard CRT for locally advanced NSCLC: GRADE recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) | 1-gen-2021 | Merlotti, A.; Bruni, A.; Borghetti, P.; Ramella, S.; Scotti, V.; Trovo, M.; Chiari, R.; Lohr, F.; Ricardi, U.; Bria, E.; Pappagallo, G. L.; D'Angelillo, R. M.; Arcangeli, S. | |
| Postoperative radiotherapy (PORT) in NSCLC: The end of a love? It is never too good to trust what appears | 1-gen-2022 | Arcangeli, S.; Ramella, S. | |
| Open issues in the therapeutic management of unresectable stage III NSCLC in the immunotherapy era | 1-gen-2022 | Catania, C.; Piperno, G.; Russo, A.; Greco, C.; Agustoni, F.; Scotti, V.; Proto, C.; Sangalli, C.; Patani, F.; Santacaterina, A.; Di Pietro Paolo, M.; Agresti, B.; Filippi, A. R.; Ramella, S. | |
| Role of Postoperative Radiotherapy in the Management for Resected NSCLC – Decision Criteria in Clinical Routine Pre- and Post-LungART | 1-gen-2021 | Suveg, K.; Le Pechoux, C.; Faivre-Finn, C.; Putora, P. M.; De Ruysscher, D.; Widder, J.; Van Houtte, P.; Troost, E. G. C.; Slotman, B. J.; Ramella, S.; Pottgen, C.; Peeters, S. T. H.; Nestle, U.; Mcdonald, F.; Dziadziuszko, R.; Belderbos, J.; Ricardi, U.; Manapov, F.; Lievens, Y.; Geets, X.; Dieckmann, K.; Guckenberger, M.; Andratschke, N.; Glatzer, M. | |
| Treatment of oropharyngeal squamous cell carcinoma: Is swallowing quality better after TORS or RT? | 1-gen-2023 | Campo, F.; Iocca, O.; De Virgilio, A.; Mazzola, F.; Mercante, G.; Pichi, B.; Holsinger, F. C.; Di Maio, P.; Ramella, S.; Pellini, R. | |
| A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study | 1-gen-2023 | Nicosia, L.; Franceschini, D.; Perrone-Congedi, F.; Molinari, A.; Gerardi, M. A.; Rigo, M.; Mazzola, R.; Perna, M.; Scotti, V.; Fodor, A.; Iurato, A.; Pasqualetti, F.; Gadducci, G.; Chiesa, S.; Niespolo, R. M.; Bruni, A.; Cappelli, A.; D'Angelo, E.; Borghetti, P.; Di Marzo, A.; Ravasio, A.; De Bari, B.; Sepulcri, M.; Aiello, D.; Mortellaro, G.; Sangalli, C.; Franceschini, M.; Montesi, G.; Aquilanti, F. M.; Lunardi, G.; Valdagni, R.; Fazio, I.; Scarzello, G.; Vavassori, V.; Maranzano, E.; Maria Magrini, S.; Arcangeli, S.; Gambacorta, M. A.; Valentini, V.; Paiar, F.; Ramella, S.; Di Muzio, N. G.; Loi, M.; Jereczek-Fossa, B. A.; Casamassima, F.; Osti, M. F.; Scorsetti, M.; Alongi, F. | |
| Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium | 1-gen-2023 | Kroeze, S. G. C.; Pavic, M.; Stellamans, K.; Lievens, Y.; Becherini, C.; Scorsetti, M.; Alongi, F.; Ricardi, U.; Jereczek-Fossa, B. A.; Westhoff, P.; But-Hadzic, J.; Widder, J.; Geets, X.; Bral, S.; Lambrecht, M.; Billiet, C.; Sirak, I.; Ramella, S.; Giovanni Battista, I.; Benavente, S.; Zapatero, A.; Romero, F.; Zilli, T.; Khanfir, K.; Hemmatazad, H.; de Bari, B.; Klass, D. N.; Adnan, S.; Peulen, H.; Salinas Ramos, J.; Strijbos, M.; Popat, S.; Ost, P.; Guckenberger, M. | |
| The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group | 1-gen-2021 | Franzese, C.; Marvaso, G.; Francolini, G.; Borghetti, P.; Trodella, L. E.; Sepulcri, M.; Matrone, F.; Nicosia, L.; Timon, G.; Ognibene, L.; Vinciguerra, A.; Alongi, F.; Bortolus, R.; Corti, L.; Ramella, S.; Magrini, S. M.; Livi, L.; Jereczek-Fossa, B. A.; Scorsetti, M.; Arcangeli, S. | |
| Management of the patient with extensive stage microcytoma. The importance of collaboration between oncology and radiotherapy | 1-gen-2023 | Minuti, G.; Stefani, A.; Trodella, L.; Cappellini, G. A.; Cecere, F.; Dionisi, F.; Di Salvatore, M.; Mariotti, S.; Mazzarella, C.; Nelli, F.; Pisegna, S.; Ricciardi, S.; Russano, M.; Ramella, S.; Bria, E.; Cappuzzo, F. | |
| A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study | 1-gen-2022 | Nicosia, L.; Franceschini, D.; Perrone-Congedi, F.; Casamassima, F.; Gerardi, M. A.; Rigo, M.; Mazzola, R.; Perna, M.; Scotti, V.; Fodor, A.; Iurato, A.; Pasqualetti, F.; Gadducci, G.; Chiesa, S.; Niespolo, R. M.; Bruni, A.; Alicino, G.; Frassinelli, L.; Borghetti, P.; Di Marzo, A.; Ravasio, A.; De Bari, B.; Sepulcri, M.; Aiello, D.; Mortellaro, G.; Sangalli, C.; Franceschini, M.; Montesi, G.; Aquilanti, F. M.; Lunardi, G.; Valdagni, R.; Fazio, I.; Scarzello, G.; Corti, L.; Vavassori, V.; Maranzano, E.; Magrini, S. M.; Arcangeli, S.; Gambacorta, M. A.; Valentini, V.; Paiar, F.; Ramella, S.; Di Muzio, N. G.; Livi, L.; Jereczek-Fossa, B. A.; Osti, M. F.; Scorsetti, M.; Alongi, F. | |
| Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E2-RADIatE OligoCare cohort | 1-gen-2024 | Alongi, F.; Nicosia, L.; Ricardi, U.; Scorsetti, M.; Greto, D.; Balermpas, P.; Lievens, Y.; Braam, P.; Jereczek-Fossa, B. A.; Stellamans, K.; Ratosa, I.; Simek, I. -M.; Peulen, H.; Dirix, P.; Verbeke, L.; Ramella, S.; Hemmatazad, H.; Khanfir, K.; Geets, X.; Jeene, P.; Zilli, T.; Fournier, B.; Fortpied, C.; Boakye Oppong, F.; Ost, P.; Guckenberger, M. | |
| Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy: Real-world data from the E2-RADIatE OligoCare cohort | 1-gen-2024 | Bultijnck, R.; Van Hemelrijck, M.; Fonteyne, V.; Livi, L.; Jereczek-Fossa, B. A.; Hemmatazad, H.; Mayinger, M.; Peulen, H.; Verbeke, L.; Ramella, S.; Castro, P.; Tsoutsou, P.; Stellamans, K.; Shaukat, A.; Orazem, M.; Jeene, P.; Braam, P.; Verkooijen, H.; Simek, I. -M.; Alongi, F.; Clementel, E.; Fortpied, C.; Machingura, A.; Boakye Oppong, F.; Guckenberger, M.; Ost, P. | |
| Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study | 1-gen-2024 | Christ, S. M.; Alongi, F.; Ricardi, U.; Scorsetti, M.; Livi, L.; Balermpas, P.; Lievens, Y.; Braam, P.; Jereczek-Fossa, B. A.; Stellamans, K.; Ratosa, I.; Widder, J.; Peulen, H.; Dirix, P.; Bral, S.; Ramella, S.; Hemmatazad, H.; Khanfir, K.; Geets, X.; Jeene, P.; Zilli, T.; Fournier, B.; Ivaldi, G. B.; Clementel, E.; Fortpied, C.; Oppong, F. B.; Ost, P.; Guckenberger, M. | |
| Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis | 1-gen-2021 | Passiglia, F.; Cinquini, M.; Bertolaccini, L.; Del Re, M.; Facchinetti, F.; Ferrara, R.; Franchina, T.; Larici, A. R.; Malapelle, U.; Menis, J.; Passaro, A.; Pilotto, S.; Ramella, S.; Rossi, G.; Trisolini, R.; Novello, S. | |
| Stage I Stereotactic Body Radiation Therapy Outcome's Prediction Models: Perfection Is the Enemy of Utility | 1-gen-2023 | Ramella, S.; Soda, P. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista14945
Data di pubblicazione
- In corso di stampa3
- 2020 - 20265521
- 2010 - 20195420
- 2000 - 20092824
- 1990 - 1999987
- 1980 - 1989188
- 1979 - 19792
Editore
- LIPPINCOTT WILLIAMS & WILKINS...3
- Edizioni Luigi Pozzi1
- Elsevier Health Sciences1
- IEEE Control Systems Society1
- IWA Publishing1
- Nova Science Publishers Inc.1
- Sauro Pierucci1
- Sauro Pierucci - AIDIC Servizi S....1
Rivista
- JOURNAL OF CLINICAL MEDICINE157
- PLOS ONE116
- SCIENTIFIC REPORTS104
- SENSORS86
- DIABETES/METABOLISM RESEARCH AND ...85
- PLASTIC AND RECONSTRUCTIVE SURGERY83
- CANCERS80
- LA CLINICA TERAPEUTICA70
- GYNECOLOGIC ONCOLOGY58
- ANNALS OF ONCOLOGY57
Keyword
- Humans640
- Female267
- Male237
- COVID-19178
- Middle Aged164
- Adult156
- Aged148
- SARS-CoV-2123
- Italy115
- Treatment Outcome84
Lingua
- eng10887
- ita654
- fre9
- spa8
- ger3
- hrv3
- und3
- bos2
- cat1
- ira1
Accesso al fulltext
- no fulltext8595
- open3514
- reserved2459
- restricted364
- partially open12
- mixed1